Thomas Trimarchi
About Thomas Trimarchi
Thomas Trimarchi serves as the Chief Product Officer at BridgeBio and has a background in biotechnology and pharmaceuticals, including previous roles at Regeneron Pharmaceuticals and Goldman Sachs. He holds a PhD in Molecular Oncology and Immunology and a Bachelor of Science in Biology.
Work at BridgeBio
Thomas Trimarchi has served as the Chief Product Officer at BridgeBio since 2018. In this role, he is responsible for overseeing product development and strategy within the organization. His tenure has been marked by a focus on advancing innovative therapies and ensuring alignment with the company's mission to address genetic diseases. He operates within the New York City Metropolitan Area, contributing to BridgeBio's efforts in the biotechnology sector.
Previous Experience at Regeneron Pharmaceuticals
Before joining BridgeBio, Thomas Trimarchi worked at Regeneron Pharmaceuticals, Inc. from 2017 to 2018. He held a position in Strategy focused on Immunology and Inflammation. During his time at Regeneron, he contributed to strategic initiatives aimed at enhancing the company's product offerings in the immunology space. His experience in this role provided him with insights into the complexities of drug development in the biopharmaceutical industry.
Experience at Goldman Sachs
Thomas Trimarchi was employed at Goldman Sachs from 2015 to 2017 as part of the Biotechnology Equity Research team. In this capacity, he analyzed biotechnology companies and provided insights that informed investment decisions. His work involved evaluating market trends and assessing the potential of various biotech firms, contributing to the firm's understanding of the sector's dynamics.
Education and Expertise
Thomas Trimarchi earned a Doctor of Philosophy (PhD) in Molecular Oncology and Immunology, Cell and Molecular Biology. He studied at New York Medicine Jobs, where he developed a deep understanding of the biological mechanisms underlying disease. Additionally, he holds a Bachelor of Science (B.S.) in Biology from the University of Vermont. His educational background equips him with the knowledge necessary for his roles in biotechnology and pharmaceuticals.
Board Membership at debra of America
Since 2020, Thomas Trimarchi has been a member of the Board of Directors at debra of America. In this role, he participates in governance and strategic planning for the organization, which focuses on supporting individuals affected by epidermolysis bullosa (EB). His involvement reflects a commitment to contributing to the community and advancing the mission of the organization.